Welcome to our dedicated page for Cadre Holdings news (Ticker: $CDRE), a resource for investors and traders seeking the latest updates and insights on Cadre Holdings stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cadre Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cadre Holdings's position in the market.
Cadre Holdings, Inc. (NYSE: CDRE) reported strong first quarter 2024 financial results, achieving record net sales of $137.9 million and gross profit of $57.6 million. The company reaffirmed its full-year guidance and declared a quarterly cash dividend. Cadre completed high-margin acquisitions, which led to a growth in net sales and gross margin. Despite increased expenses, the company generated $6.9 million in net income and $24.5 million in Adjusted EBITDA for the quarter.
